Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale President and CEO sold 8,223 shares at $12.53 ($103,051)
  2. 4 Open-market sale Chief Operations Officer sold 2,426 shares at $12.53 ($30,403)
  3. 4 Open-market sale SVP, GC & Secretary sold 2,080 shares at $12.53 ($26,067)
  4. 4 Open-market sale Chief Financial Officer sold 3,579 shares at $12.53 ($44,852)
  5. 4 Open-market sale EVP, Head of R&D sold 2,152 shares at $12.53 ($26,969)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale President and CEO sold 14,194 shares at $16.32 ($231,660)
  9. 4 Open-market buy Chief Commercial Officer bought 34,354 shares at an average $14.57 ($500,370)
  10. 4 Grant or award Director acquired 11,000 shares (grant or award)
  11. 4 Grant or award Director acquired 11,000 shares (grant or award)
  12. 4 Grant or award Director acquired 11,000 shares (grant or award)
  13. 4 Grant or award Director acquired 11,000 shares (grant or award)
  14. 4 Grant or award Director acquired 11,000 shares (grant or award)
  15. 4 Grant or award Director acquired 11,000 shares (grant or award)
  16. 4 Grant or award Director acquired 11,000 shares (grant or award)
  17. 4 Grant or award Director acquired 11,000 shares (grant or award)
  18. 4 Open-market sale Chief Financial Officer sold 5,820 shares at $14.06 ($81,829)
  19. 4 Open-market sale Chief Operations Officer sold 2,453 shares at $14.55 ($35,691)
  20. 4 Open-market sale EVP, Head of R&D sold 5,184 shares at $14.55 ($75,427)

Page 9 of 33 · 644 filings